These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1951207

  • 1. Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (Lotrisone).
    Reynolds RD, Boiko S, Lucky AW.
    Am J Dis Child; 1991 Nov; 145(11):1224-5. PubMed ID: 1951207
    [No Abstract] [Full Text] [Related]

  • 2. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.
    Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP.
    Pediatr Dermatol; 2002 Nov; 19(1):78-81. PubMed ID: 11860579
    [Abstract] [Full Text] [Related]

  • 3. Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream).
    Barkey WF.
    J Am Acad Dermatol; 1987 Sep; 17(3):518-9. PubMed ID: 3655035
    [No Abstract] [Full Text] [Related]

  • 4. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents.
    Alston SJ, Cohen BA, Braun M.
    Pediatrics; 2003 Jan; 111(1):201-3. PubMed ID: 12509578
    [Abstract] [Full Text] [Related]

  • 5. SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis.
    Katz HI, Bard J, Cole GW, Fischer S, McCormick GE, Medansky RS, Nesbitt LT, Rex IH.
    Cutis; 1984 Aug; 34(2):183-8. PubMed ID: 6383734
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
    Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J.
    J Am Acad Dermatol; 1992 Jan; 26(1):125-7. PubMed ID: 1732321
    [No Abstract] [Full Text] [Related]

  • 7. Use of clotrimazole/betamethasone diproprionate by family physicians.
    Shaffer MP, Feldman SR, Fleischer AB.
    Fam Med; 2000 Sep; 32(8):561-5. PubMed ID: 11002867
    [Abstract] [Full Text] [Related]

  • 8. A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product.
    Wortzel MH.
    Cutis; 1982 Aug; 30(2):258-61. PubMed ID: 6751707
    [No Abstract] [Full Text] [Related]

  • 9. Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency.
    Railan D, Wilson JK, Feldman SR, Fleischer AB.
    Dermatol Online J; 2002 Oct; 8(2):3. PubMed ID: 12546758
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
    Spiekermann PH, Young MD.
    Arch Dermatol; 1976 Mar; 112(3):350-2. PubMed ID: 769697
    [Abstract] [Full Text] [Related]

  • 11. Perianal ulcerations from topical steroid use.
    Adams BB, Sheth PB.
    Cutis; 2002 Jan; 69(1):67-8. PubMed ID: 11829184
    [Abstract] [Full Text] [Related]

  • 12. Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections.
    Rosen T, Elewski BE.
    J Am Acad Dermatol; 1995 Jun; 32(6):1050-1. PubMed ID: 7751452
    [No Abstract] [Full Text] [Related]

  • 13. How I treat tinea corporis.
    Crain WR.
    Med Times; 1980 Aug; 108(8):38, 40. PubMed ID: 7402001
    [No Abstract] [Full Text] [Related]

  • 14. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
    Bogaert H, Cordero C, Ollague W, Savin RC, Shalita AR, Zaias N.
    J Int Med Res; 1986 Aug; 14(4):210-6. PubMed ID: 3530834
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A, Pandhi D, Agrawal S, Das S.
    J Dermatolog Treat; 2005 Aug; 16(5-6):331-5. PubMed ID: 16428155
    [Abstract] [Full Text] [Related]

  • 16. Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis.
    Tanenbaum L, Taplin D, Lavelle C, Akers WA, Rosenberg MJ, Carmargo G.
    Cutis; 1989 Oct; 44(4):344-7. PubMed ID: 2805811
    [Abstract] [Full Text] [Related]

  • 17. Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians.
    Balkrishnan R, Cook JM, Shaffer MP, Saltzberg FB, Feldman SR, Fleischer AB.
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):133-8. PubMed ID: 15072111
    [Abstract] [Full Text] [Related]

  • 18. Topical treatment of common superficial tinea infections.
    Weinstein A, Berman B.
    Am Fam Physician; 2002 May 15; 65(10):2095-102. PubMed ID: 12046779
    [Abstract] [Full Text] [Related]

  • 19. Fulminant papulopustular tinea corporis caused by Trichophyton mentagrophytes.
    Bornkessel A, Ziemer M, Yu S, Hipler C, Elsner P.
    Acta Derm Venereol; 2005 May 15; 85(1):92. PubMed ID: 15849010
    [No Abstract] [Full Text] [Related]

  • 20. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994.
    Smith ES, Fleischer AB, Feldman SR.
    J Am Acad Dermatol; 1998 Jul 15; 39(1):43-7. PubMed ID: 9674396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.